Prospective sonographic evaluation of interluekin-2-induced changes in the gallbladder

Radiology

Volumn 206, Issue 2, 1998, Pages 393-396

  Premkumar, Ahalya ^a   Walworth, Charles M ^a   Vogel, Susan ^b   Daryanani, Kailash D ^a   Venzon, David J ^c   Kovacs, Joseph A ^a   Feuerstein, Irwin M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gallbladder, US; Gallbladder, wall thickening; Lymphokines

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; CONTINUOUS INFUSION; ECHOGRAPHY; GALLBLADDER DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL;

EID: 0031889213     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.206.2.9457191     Document Type: Article

References (20)

1. Farrar JJ, Benjamin WR, Hilfiker ML, Howard M, Farrar WL, Fuller-Farrar J. The biochemistry, biology and role of interleukin-2 in the induction of cytotoxic T-cell and antibodyforming B-cell responses. Immunol Rev 1982; 63:129-166.
2. Lotze MT, Frana LW, Sharrow SO, Robb RJ, Rosenberg SA. In vivo administration of purified human interleukin-2. J Immunol 1985; 134:157-166.
3. Whittington R, Faulds D. Interleukin-2: a review of its pharmacological properties and therapeutic use in patients with cancer. Drugs 1993; 46:446-514.
4. Kovacs J A, Baseler M, Dewar R, et al. Increases in CD4+ lymphocytes with intermittent courses of continuous interleukin-2 infusions in patients with human immunodeficiency virus infection: a preliminary study. N Engl J Med 1995; 332:567-575.
5. Kovacs JA, Vogel S, Albert JM, et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med 1996; 335:1350-1564.
6. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-1170.
7. Lane HC, Siegel JP, Rook AH, et al. Use of interleukin-2 in patients with acquired immunodeficiency syndrome. J Biol Response Mod 1984; 3:512-516.
8. Schnittman SM, Vogel S, Baseler M, et al. A phase 1 study of interferon alfa-2b in combination with interleukin-2 in patients with immunodeficiency virus infection. J Infect Dis 1994; 169:981-989.
9. Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313:1485-1492.
10. Margolin KA, Rayner AA, Hawkins MJ, et al. Interleukin-2 and lymphokine activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines. J Clin Oncol 1989; 7:486-498.
11. Nakagawa K, Miller FN, Sims DE, Lentsh AB, Miyazaki M, Edwards MJ. Mechanisms of interleukin-2 induced hepatotoxicity. Cancer Res 1996; 56:507-510.
12. Fisher B, Keenan AM, Garra B, et al. Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients. J Clin Oncol 1989; 7:1852-1862.
13. Chung-Park M, Kim B, Marmolya G, Karlins N, Wojcik E. Acalculous lymphoeosinophilic cholecystitis associated with interleukin-2 and lymphokine-killer activated cell therapy. Arch Pathol Lab Med 1990; 114:1073-1075.
14. Powell FC, Spooner KM, Shawker TH, et al. Symptomatic interleukin-2 induced cholecystopathy in patients with HIV infection. AJR 1994; 163:117-121.
15. Dickey KW, Barth RA, Stewart JA. Recurrent transient gall bladder wall thickening associated with interleukin-2 therapy. JCU 1993; 21:58-61.
16. Handler SJ. Ultrasound of gall bladder wall thickening and its relation to cholecystitis. AJR 1979; 132:581-585.
17. Laing FC. Diagnostic evaluation of patients with suspected acute cholecystitis. Radiol Clin North Am 1983; 21:477-493.
18. Lim JH, Ko YT, Kim SY. Ultrasonic changes of the gall bladder wall in cholecystitis: sonographic-pathological correlation. Clin Radiol 1987; 38:389-393.
19. Sharp KW. Acute cholecystitis. Surg Clin North Am 1988; 68:269-279.
20. Cohen RH, Mahony BS, Bowie JD, Cooper C, Baker ME, Illescas FF. Striated intraluminal gallbladder lucencies on US studies: predictors of acute cholecystitis. Radiology 1987; 164:31-35.